Hereditary susceptibility to diabetes is defined by a set of genetic variations in various genes. A disposition to develop diabetes type 2 includes insulini resistance.
1. |
Horikawa Y et al. (2008) Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. |
2. |
et. al. (2010) Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. |
3. |
Okamoto K et al. (2010) Identification of KCNJ15 as a susceptibility gene in Asian patients with type 2 diabetes mellitus. |
4. |
Kong A et al. (2009) Parental origin of sequence variants associated with complex diseases. |
5. |
Perry JR et al. (2010) Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes. |
6. |
Ding EL et al. (2009) Sex hormone-binding globulin and risk of type 2 diabetes in women and men. |
7. |
Lyssenko V et al. (2008) Clinical risk factors, DNA variants, and the development of type 2 diabetes. |
8. |
Meigs JB et al. (2008) Genotype score in addition to common risk factors for prediction of type 2 diabetes. |
9. |
Prokopenko I et al. (2008) Type 2 diabetes: new genes, new understanding. |
10. |
Yasuda K et al. (2008) Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. |
11. |
Unoki H et al. (2008) SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. |
13. |
Dentin R et al. (2008) Hepatic glucose sensing via the CREB coactivator CRTC2. |
14. |
van Vliet-Ostaptchouk JV et al. (2008) HHEX gene polymorphisms are associated with type 2 diabetes in the Dutch Breda cohort. |
16. |
Matsuzaka T et al. (2007) Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. |
17. |
Aeberli I et al. (2007) Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children. |
18. |
Sladek R et al. (2007) A genome-wide association study identifies novel risk loci for type 2 diabetes. |
19. |
Fuku N et al. (2007) Mitochondrial haplogroup N9a confers resistance against type 2 diabetes in Asians. |
20. |
Shtir C et al. (2007) Subsets of Finns with high HDL to total cholesterol ratio show evidence for linkage to type 2 diabetes on chromosome 6q. |
21. |
Martinez-Marignac VL et al. (2007) Admixture in Mexico City: implications for admixture mapping of type 2 diabetes genetic risk factors. |
22. |
Graham TE et al. (2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. |
23. |
Gauguier D et al. (1996) Chromosomal mapping of genetic loci associated with non-insulin dependent diabetes in the GK rat. |
24. |
Tuomi T et al. (1999) Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. |
25. |
Fonseca VA et al. (1998) Troglitazone monotherapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled study. The Troglitazone Study Group. |
26. |
Pratley RE et al. (1998) An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. |
27. |
Poulton J et al. (1998) A common mitochondrial DNA variant is associated with insulin resistance in adult life. |
28. |
Shimabukuro M et al. (1998) Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. |
29. |
Shimabukuro M et al. (1997) Leptin- or troglitazone-induced lipopenia protects islets from interleukin 1beta cytotoxicity. |
31. |
Brüning JC et al. (1997) Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. |
32. |
Lee Y et al. (1997) Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. |
33. |
Sreenan S et al. (1996) Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone. |
34. |
Fajans SS et al. (2001) Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. |
35. |
Galli J et al. (1996) Genetic analysis of non-insulin dependent diabetes mellitus in the GK rat. |
36. |
Lee Y et al. (1994) Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. |
37. |
Bogardus C et al. (1989) Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions. |
38. |
et al. (2014) Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. |
39. |
Zhou K et al. (2012) The role of ATM in response to metformin treatment and activation of AMPK. |
40. |
Woods A et al. (2012) The role of ATM in response to metformin treatment and activation of AMPK. |
41. |
Yee SW et al. (2012) The role of ATM in response to metformin treatment and activation of AMPK. |
42. |
Bonnefond A et al. (2012) Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. |
43. |
et al. (2011) Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. |
44. |
Woods A et al. (2011) LKB1 is required for hepatic bile acid transport and canalicular membrane integrity in mice. |
45. |
Scott LJ et al. (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. |
46. |
Altshuler D et al. (2000) The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. |
47. |
Fakhrai-Rad H et al. (2000) Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats. |
48. |
Piatti PM et al. (2000) Alterations in nitric oxide/cyclic-GMP pathway in nondiabetic siblings of patients with type 2 diabetes. |
49. |
Chung YS et al. (2000) HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients. |
50. |
Elbein SC et al. (1999) A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. |
51. |
Elbein SC et al. (1999) Heritability of pancreatic beta-cell function among nondiabetic members of Caucasian familial type 2 diabetic kindreds. |
52. |
Hanson RL et al. (1998) An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. |
53. |
Savage DB et al. (2002) Digenic inheritance of severe insulin resistance in a human pedigree. |
54. |
Sandhu MS et al. (2007) Common variants in WFS1 confer risk of type 2 diabetes. |
55. |
Zeggini E et al. (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. |
56. |
Yang Q et al. (2005) Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. |
57. |
et al. (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. |
58. |
Mammarella S et al. (2000) Interaction between the G1057D variant of IRS-2 and overweight in the pathogenesis of type 2 diabetes. |
59. |
None (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. |
60. |
Babenko AP et al. (2006) Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. |
61. |
Gudmundsson J et al. (2007) Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. |
62. |
Shimajiri Y et al. (2001) A missense mutation of Pax4 gene (R121W) is associated with type 2 diabetes in Japanese. |
63. |
Illig T et al. (2004) Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes. |
64. |
Möhlig M et al. (2004) Body mass index and C-174G interleukin-6 promoter polymorphism interact in predicting type 2 diabetes. |
65. |
Triggs-Raine BL et al. (2002) HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community. |
66. |
Halsall DJ et al. (2003) Typical type 2 diabetes mellitus and HFE gene mutations: a population-based case - control study. |
68. |
Mohlke KL et al. (2005) Mitochondrial polymorphisms and susceptibility to type 2 diabetes-related traits in Finns. |
69. |
Scheuner D et al. (2005) Control of mRNA translation preserves endoplasmic reticulum function in beta cells and maintains glucose homeostasis. |
70. |
Maeda S et al. (2005) Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus. |
71. |
Foti D et al. (2005) Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. |
72. |
O'Rahilly S et al. (1992) Multipoint linkage analysis of the short arm of chromosome 11 in non-insulin dependent diabetes including maturity onset diabetes of youth. |
73. |
Do DV et al. (2005) Persistent diabetic macular edema is associated with elevated hemoglobin A1c. |
74. |
Petersen KF et al. (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. |
75. |
Martin BC et al. (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. |
76. |
Garber AJ et al. (2003) Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes. |
77. |
Demenais F et al. (2003) A meta-analysis of four European genome screens (GIFT Consortium) shows evidence for a novel region on chromosome 17p11.2-q22 linked to type 2 diabetes. |
78. |
Reynisdottir I et al. (2003) Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2. |
79. |
Petersen KF et al. (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. |
81. |
Poulton J et al. (2002) Type 2 diabetes is associated with a common mitochondrial variant: evidence from a population-based case-control study. |
82. |
Mori Y et al. (2002) Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p. |
83. |
Yuan M et al. (2001) Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. |
84. |
Aljada A et al. (2001) Nuclear factor-kappaB suppressive and inhibitor-kappaB stimulatory effects of troglitazone in obese patients with type 2 diabetes: evidence of an antiinflammatory action? |
85. |
Li H et al. (2001) Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 Diabetes. |
86. |
Hart AW et al. (2000) Attenuation of FGF signalling in mouse beta-cells leads to diabetes. |
89. |
OMIM.ORG article Omim 125853 |